{"doi":"10.3390/ijms26136193","title":"Substituted Triazole-3,5-Diamine Compounds as Novel Human Topoisomerase III Beta Inhibitors","abstract":"Human topoisomerase III beta (hTOP3B) is a unique and important enzyme in human cells that plays a role in maintaining genome stability, affecting cellular aging, and potentially impacting viral replication. Its dual activity on both DNA and RNA makes it a valuable target for therapeutic interventions. hTOP3B has been shown to be required for the efficient replication of certain positive-sense ssRNA viruses including Dengue. We performed in silico screening of a library comprising drugs that are FDA-approved or undergoing clinical trials as potential drugs to identify potential inhibitors of hTOP3B. The topoisomerase activity assay of the identified virtual hits showed that bemcentinib, a compound known to target the AXL receptor tyrosine kinase, can inhibit hTOP3B relaxation activity. This is the first small molecule shown to inhibit the complete catalytic cycle of hTOP3B for the potential interference of the function of hTOP3B in antiviral application. Additional small molecules that share the N5,N3-1H-1,2,4-triazole-3,5-diamine moiety of bemcentinib were synthesized and tested for the inhibition of hTOP3B relaxation activity. Five compounds with comparable IC50 to that of bemcentinib for the inhibition of hTOP3B were identified. These results suggest that the exploration of tyrosine kinase inhibitors and their analogs may allow the identification of novel potential topoisomerase inhibitors.","journal":"International Journal of Molecular Sciences","year":2025,"id":541598,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9573,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1298862,"name":"Somaia Haque Chadni","orcid":"0000-0001-6088-3659","position":1,"is_corresponding":false},{"id":1097830,"name":"Ramanjaneyulu Rayala","orcid":"0000-0002-0198-6903","position":2,"is_corresponding":false},{"id":1429878,"name":"Hasham S. Sofi","orcid":"0000-0002-0747-6090","position":3,"is_corresponding":false},{"id":466372,"name":"Shomita Ferdous","orcid":null,"position":4,"is_corresponding":false},{"id":763339,"name":"Rudramani Pokhrel","orcid":"0000-0002-7208-0420","position":5,"is_corresponding":false},{"id":1303502,"name":"Adel Nefzi","orcid":"0000-0003-0155-5887","position":6,"is_corresponding":false},{"id":291399,"name":"Prem P. Chapagain","orcid":"0000-0002-0999-4975","position":7,"is_corresponding":false},{"id":348578,"name":"Yuk‐Ching Tse‐Dinh","orcid":"0000-0002-5616-5176","position":8,"is_corresponding":false},{"id":1280640,"name":"Yasir Mamun","orcid":"0000-0001-6479-6923","position":0,"is_corresponding":true}],"reference_count":51,"raw_metadata":null,"created_at":"2026-07-19T02:52:47.161928Z","pmid":"40649971","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}